NCT05219838View on ClinicalTrials.gov

Binding and Effects of Lu AG06466 in the Brain of Healthy Men

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

January 18, 2022

Primary Completion Date

August 18, 2022

Study Completion Date

August 29, 2022

Conditions

Healthy Participants

Interventions

DRUG

Lu AG06466

Lu AG06466 will be administered per dose and schedule specified in the arm description.

Trial Locations (1)

06510

Invicro, LLC, New Haven

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY